These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4006810)

  • 41. Impact of measles outbreak response vaccination campaign in Dar es Salaam, Tanzania.
    Goodson JL; Wiesen E; Perry RT; Mach O; Kitambi M; Kibona M; Luman ET; Cairns KL
    Vaccine; 2009 Sep; 27(42):5870-4. PubMed ID: 19656496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
    Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M
    Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Specific anti-measles prophylaxis in Rumania. 3. Comparative study of some live attenuated virus vaccines].
    Cajal N; Cepleanu M; Cernescu C; Sorodoc Y
    Stud Cercet Inframicrobiol; 1969; 20(4):275-85. PubMed ID: 5371258
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi.
    Helfand RF; Witte D; Fowlkes A; Garcia P; Yang C; Fudzulani R; Walls L; Bae S; Strebel P; Broadhead R; Bellini WJ; Cutts F
    J Infect Dis; 2008 Nov; 198(10):1457-65. PubMed ID: 18828743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical and serological observations of children vaccinated with measles vaccine and those not vaccinated during an epidemic in an inpatient institution].
    Polna I; Szkudlarek D
    Pediatr Pol; 1979 Jan; 54(1):53-60. PubMed ID: 424255
    [No Abstract]   [Full Text] [Related]  

  • 47. Response of mildly to moderately malnourished children to measles vaccination.
    Baer CL; Bratt DE; Edwards R; McFarlane H; Utermohlen V
    West Indian Med J; 1986 Jun; 35(2):106-11. PubMed ID: 3739339
    [No Abstract]   [Full Text] [Related]  

  • 48. [Status of immunity after measles vaccination (author's transl)].
    La Cauza C; Galluzzi F; Salti R
    Ann Sclavo; 1980; 22(4):545-54. PubMed ID: 7018418
    [No Abstract]   [Full Text] [Related]  

  • 49. Antibody titres after measles vaccine.
    Ghosh S; Kumari S; Bhargava SK
    Indian J Med Res; 1977 Aug; 66(2):165-71. PubMed ID: 924590
    [No Abstract]   [Full Text] [Related]  

  • 50. [Indications and contraindications for the measles vaccination of children with an aggravated neurological anamnesis].
    Kossova ET; Dadiomova MA; Lakotkina EA; Ryzhova TP
    Tr Inst Im Pastera; 1979; 53():40-3. PubMed ID: 262710
    [No Abstract]   [Full Text] [Related]  

  • 51. [Virologic and clinical observations after active measles vaccination. 2].
    Haas R; Vivell O; Buentello-Malo L; Reiss G; Berning D
    Dtsch Med Wochenschr; 1966 Apr; 91(13):569-74. PubMed ID: 5930702
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunological response to measles vaccination in poor communities.
    Bhaskaram P; Madhusudan J; Radhrakrishna KV; Raj S
    Hum Nutr Clin Nutr; 1986 Jul; 40(4):295-9. PubMed ID: 3744889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measles vaccination in severely malnourished Sudanese children.
    Idris S; El Seed AM
    Ann Trop Paediatr; 1983 Jun; 3(2):63-7. PubMed ID: 6197010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effectiveness of selective anti-measles reimmunization of risk-group children].
    Sokhin AA; Ignatov SA
    Pediatriia; 1988; (9):69-72. PubMed ID: 3200643
    [No Abstract]   [Full Text] [Related]  

  • 55. Investigation of the effectiveness of measles vaccination in children in Kenya.
    Bell TM; Tukei PM; Ademba GR; Mbugua FM; Gathara GW; Magana JM; Kinyanjui P; Muli J; Hazlett DT; Alwar JE
    J Hyg (Lond); 1985 Dec; 95(3):695-702. PubMed ID: 3912434
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Reactions of immunoglobulins and specific antibodies in vaccinated and nonvaccinated children with measles (author's transl].
    Wiedermannová D; Wiedermann D; Bozdĕchová M; Pejćochová J
    Cas Lek Cesk; 1977 Feb; 116(7):205-9. PubMed ID: 851980
    [No Abstract]   [Full Text] [Related]  

  • 57. Persistence of measles antibody after immunization.
    Domorázková E; Drevo M
    J Biol Stand; 1975; 3(2):225-30. PubMed ID: 1126966
    [No Abstract]   [Full Text] [Related]  

  • 58. [Measles vaccination].
    Huisman J
    Ned Tijdschr Geneeskd; 1975 Apr; 119(17):671-3. PubMed ID: 1143549
    [No Abstract]   [Full Text] [Related]  

  • 59. Measles vaccination in infants.
    Jones PH
    JAMA; 1982 Mar; 247(9):1273-4. PubMed ID: 7062536
    [No Abstract]   [Full Text] [Related]  

  • 60. Measles vaccination in a rural Tanzanian community.
    King B
    East Afr Med J; 1978 Jun; 55(6):252-5. PubMed ID: 699835
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.